Cardiac rupture associated with thrombolytic therapy: impact of time to treatment in the Late Assessment of Thrombolytic Efficacy (LATE) study

Thrombosis Research Center, University of Massachusetts Medical School, Worcester.

OBJECTIVES. This prospective ancillary study was conducted to determine the association between the time from symptom onset to treatment and cardiac rupture in patients with acute myocardial infarction. BACKGROUND. There is strong evidence that the time window for thrombolytic therapy should be extended to at least 12 h; however, many clinicians are concerned that late treatment may cause an excessive occurrence of death from cardiac rupture. Because up to 30% of patients with acute myocardial infarction arrive in the hospital > 6 h from symptom onset, resolving this issue is of paramount clinical importance. METHODS. A total of 5,711 patients with acute myocardial infarction were randomized to receive intravenous recombinant tissue-type plasminogen activator (rt-PA) (100 mg over 3 h) or matching placebo, within 6 and 24 h from symptom onset. Both groups received immediate oral aspirin, and a majority of patients received intravenous heparin during the initial 48 h. RESULTS. By 35 days, 177 patients had died, with the cause of death specified as cardiac rupture (53 patients), electromechanical dissociation (42 patients) or asystole (82 patients). An additional 370 patients had died of other causes. In patients treated within 12 h, the proportion of rupture deaths in the group given rt-PA was higher than that observed in those who received placebo, but the difference was not statistically significant. In patients treated after 12 h, there was no evidence of an increased incidence of rupture with rt-PA, and the proportion of deaths due to rupture in this group was lower than that in patients given placebo. However, there was evidence of a difference between rt-PA and placebo with respect to the time that rupture became clinically manifest (treatment by time to death interaction, p = 0.03). CONCLUSIONS. This study provides unequivocal evidence that late treatment (6 to 24 h after symptom onset) with rt-PA is not associated with an increased risk of cardiac rupture. However, for reasons that are unclear, coronary thrombolysis appears to accelerate rupture events, typically to within 24 h of treatment.

This article has been cited by other articles:

				D. A. De Silva, J. J. F. Manzano, H. M. Chang, and M. C. Wong Reconsidering recent myocardial infarction as a contraindication for IV stroke thrombolysis Neurology, May 24, 2011; 76(21): 1838 - 1840. [Abstract] [Full Text] [PDF]

				J. Lopez-Sendon, E. P. Gurfinkel, E. Lopez de Sa, G. Agnelli, J. M. Gore, P. G. Steg, K. A. Eagle, J. R. Cantador, G. Fitzgerald, C. B. Granger, et al. Factors related to heart rupture in acute coronary syndromes in the Global Registry of Acute Coronary Events Eur. Heart J., June 2, 2010; 31(12): 1449 - 1456. [Abstract] [Full Text] [PDF]

				H. R. Reynolds and J. S. Hochman Cardiogenic Shock: Current Concepts and Improving Outcomes Circulation, February 5, 2008; 117(5): 686 - 697. [Full Text] [PDF]

				A. K. Agnihotri, J. C. Madsen, and W. M. Daggett Jr Surgical Treatment of Complications of Acute Myocardial Infarction: Postinfarction Ventricular Septal Defect and Free Wall Rupture Card. Surg. Adult, January 1, 2008; 3(2008): 753 - 784. [Full Text]

				G. Weissman, C. C. Kwon, R. K. Shaw, and J. F. Setaro Free-Wall Rupture of the Myocardium Following Infarction: A Changing Clinical Portrait in the Reperfusion Era: A Case Report Angiology, October 1, 2006; 57(5): 636 - 642. [Abstract] [PDF]

				H. Bueno, M. Martinez-Selles, E. Perez-David, and R. Lopez-Palop Effect of thrombolytic therapy on the risk of cardiac rupture and mortality in older patients with first acute myocardial infarction Eur. Heart J., September 1, 2005; 26(17): 1705 - 1711. [Abstract] [Full Text] [PDF]

				B. J. Gersh, G. W. Stone, H. D. White, and D. R. Holmes Jr Pharmacological Facilitation of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: Is the Slope of the Curve the Shape of the Future? JAMA, February 23, 2005; 293(8): 979 - 986. [Abstract] [Full Text] [PDF]

				X.-M. Gao, Q. Xu, H. Kiriazis, A. M. Dart, and X.-J. Du Mouse model of post-infarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology Cardiovasc Res, February 1, 2005; 65(2): 469 - 477. [Abstract] [Full Text] [PDF]

				H.-K. Yip, C.-Y. Fang, K.-T. Tsai, H.-W. Chang, K.-H. Yeh, M. Fu, and C.-J. Wu The Potential Impact of Primary Percutaneous Coronary Intervention on Ventricular Septal Rupture Complicating Acute Myocardial Infarction Chest, May 1, 2004; 125(5): 1622 - 1628. [Abstract] [Full Text] [PDF]

				H.-K. Yip, C.-J. Wu, H.-W. Chang, C.-P. Wang, C.-I Cheng, S. Chua, and M.-C. Chen Cardiac Rupture Complicating Acute Myocardial Infarction in the Direct Percutaneous Coronary Intervention Reperfusion Era Chest, August 1, 2003; 124(2): 565 - 571. [Abstract] [Full Text] [PDF]

				A. K. Agnihotri, J. C. Madsen, and W. M. Daggett Jr. Surgical Treatment of Complications of Acute Myocardial Infarction: Postinfarction Ventricular Septal Defect and Free Wall Rupture Card. Surg. Adult, January 1, 2003; 2(2003): 681 - 714. [Full Text]

				V. Mantovani, D. Vanoli, P. Chelazzi, V. Lepore, S. Ferrarese, and A. Sala Post-infarction cardiac rupture: surgical treatment Eur J Cardiothorac Surg, November 1, 2002; 22(5): 777 - 780. [Abstract] [Full Text] [PDF]

				J. A.R. Pluth Invited commentary Ann. Thorac. Surg., July 1, 2002; 74(1): 101 - 101. [Full Text] [PDF]

				G R Rhydwen, S Charman, and P M Schofield Influence of thrombolytic therapy on the patterns of ventricular septal rupture after acute myocardial infarction Postgrad. Med. J., July 1, 2002; 78(921): 408 - 412. [Abstract] [Full Text] [PDF]

				M. E. Khalil, E. N. Heller, F. Boctor, E. J. Brown Jr, and I. A. Alhaddad Ventricular Free Wall Rupture in Acute Myocardial Infarction Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2001; 6(3): 231 - 236. [Abstract] [PDF]

				M. H. McMullan, M. D. Maples, T. L. Kilgore Jr, and S. H. Hindman Surgical experience with left ventricular free wall rupture Ann. Thorac. Surg., June 1, 2001; 71(6): 1894 - 1899. [Abstract] [Full Text] [PDF]

				W. M. Park, C. P. Connery, J. S. Hochman, M. D. Tilson, and C. E. Anagnostopoulos Successful repair of myocardial free wall rupture after thrombolytic therapy for acute infarction Ann. Thorac. Surg., October 1, 2000; 70(4): 1345 - 1349. [Abstract] [Full Text] [PDF]

				R. Pretre, P. Benedikt, and M. I. Turina Experience with postinfarction left ventricular free wall rupture Ann. Thorac. Surg., May 1, 2000; 69(5): 1342 - 1345. [Abstract] [Full Text] [PDF]

				B. S. Crenshaw, C. B. Granger, Y. Birnbaum, K. S. Pieper, D. C. Morris, N. S. Kleiman, A. Vahanian, R. M. Califf, and E. J. Topol Risk Factors, Angiographic Patterns, and Outcomes in Patients With Ventricular Septal Defect Complicating Acute Myocardial Infarction Circulation, January 4, 2000; 101(1): 27 - 32. [Abstract] [Full Text] [PDF]

				R. C. Becker and G. Aurigemma Reply J. Am. Coll. Cardiol., December 1, 1999; 34(7): 2151 - 2151. [Full Text] [PDF]

				R. C. Becker, J. S. Hochman, C. P. Cannon, F. A. Spencer, S. P. Ball, M. J. Rizzo, E. M. Antman, and for the TIMI 9 Investigators Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: Observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study J. Am. Coll. Cardiol., February 1, 1999; 33(2): 479 - 487. [Abstract] [Full Text] [PDF]

				F. W. A. Verheugt The Early Risk of Thrombolytic Therapy for Acute Myocardial Infarction: Incidence, Mechanisms and Possible Prevention European Journal of Cardiovascular Prevention & Rehabilitation, April 1, 1998; 5(2): 103 - 108. [Abstract] [PDF]

				M. J. Reardon, C. L. Carr, A. Diamond, G. V. Letsou, H. J. Safi, R. Espada, and J. C. Baldwin Ischemic Left Ventricular Free Wall Rupture: Prediction, Diagnosis, and Treatment Ann. Thorac. Surg., November 1, 1997; 64(5): 1509 - 1513. [Abstract] [Full Text]